Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
S-BIO is a life science brand within Sumitomo Bakelite focused on research-use products rather than therapeutic drug development. The business supplies advanced 3D cell culture labware, including ultra-low attachment spheroid plates, as well as glycan analysis kits and related analytical solutions used in biopharma development and academic research. In North America, S-BIO products are distributed through Vaupell Midwest, a Sumitomo Bakelite subsidiary, and historical materials also describe S-BIO US as operating within Vaupell Holdings. Its offerings support drug discovery, cancer and stem cell research, regenerative medicine, and glycomics workflows. The entity appears to be an active commercial life science tools business, not a clinical-stage biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on S-Bio Vaupell Holdings.